肠道通透性
无症状的
胃肠病学
医学
危险系数
内科学
乳果糖
克罗恩病
生物标志物
甘露醇
比例危险模型
发病机制
前瞻性队列研究
疾病
势垒函数
置信区间
生物
生物化学
细胞生物学
作者
Williams Turpin,Sun-Ho Lee,Juan A. Raygoza Garay,Karen Madsen,Jonathan B. Meddings,Larbi Bedrani,Namita Power,Osvaldo Espin‐Garcia,Wei Xu,Michelle I. Smith,Anne M. Griffiths,Paul Moayyedi,Dan Turner,Ernest G. Seidman,A. Hillary Steinhart,John K. Marshall,Kevan Jacobson,David Mack,Çharles N. Bernstein,Andrew D. Paterson
出处
期刊:Gastroenterology
[Elsevier BV]
日期:2020-08-10
卷期号:159 (6): 2092-2100.e5
被引量:289
标识
DOI:10.1053/j.gastro.2020.08.005
摘要
Background & Aims Increased intestinal permeability has been associated with Crohn’s disease (CD), but it is not clear whether it is a cause or result of the disease. We performed a prospective study to determine whether increased intestinal permeability is associated with future development of CD. Methods We assessed the intestinal permeability, measured by the urinary fractional excretion of lactulose-to-mannitol ratio (LMR) at recruitment in 1420 asymptomatic first-degree relatives (6–35 years old) of patients with CD (collected from 2008 through 2015). Participants were then followed up for a diagnosis of CD from 2008 to 2017, with a median follow-up time of 7.8 years. We analyzed data from 50 participants who developed CD after a median of 2.7 years during the study period, along with 1370 individuals who remained asymptomatic until October 2017. We used the Cox proportional hazards model to evaluate time-related risk of CD based on the baseline LMR. Results An abnormal LMR (>0.03) was associated with a diagnosis of CD during the follow-up period (hazard ratio, 3.03; 95% CI, 1.64–5.63; P = 3.97 × 10–4). This association remained significant even when the test was performed more than 3 years before the diagnosis of CD (hazard ratio, 1.62; 95% CI, 1.051–2.50; P = .029). Conclusions Increased intestinal permeability is associated with later development of CD; these findings support a model in which altered intestinal barrier function contributes to pathogenesis. Abnormal gut barrier function might serve as a biomarker for risk of CD onset.
科研通智能强力驱动
Strongly Powered by AbleSci AI